integrated solutions for glp-1 and peptides The rapid growth of therapeutics is reshaping the treatment landscape diabetes obesity, creating new opportunities and new analytical challenges for developers. From structural characterization and impurity profiling to stability FDA Approves First Oral GLP-1

Nitrosylation of cystein 10 promotes dsNNTTR formation Our results demonstrate that nitrosative thiol modification efficiently promotes intermolecular disulfide bond formation in TTR, as evidenced by the prominent dsNNTTR dimer observed by non-reducing SDSPAGE following GSNO treatment

Chronic inflammation is thought to be involved in the progression of several sustained illnesses, including rheumatoid arthritis, asthma, irritable bowel syndrome, atherosclerosis, diabetes, and cancer

Mutations in the SLC25A19 gene that codes for the mitochondrial TPP transporter can result in either thiamin metabolism dysfunction syndrome-3 (THMD3) or thiamin metabolism dysfunction syndrome-4 (THMD4)

DOI: 10.1111/jdi.12493